Maternal and Fetal Risks of Natalizumab Exposure in UteroNeurol 90:443-444, Marrie, R.A.,et al, 2018
Diagnosis and Management of the Antiphospholipid SyndromeBMJ 340:1125-1132, Cohen,D., et al, 2010